Federal Agency · Defense Health Agency Contracting Activity - DHACA
DoW Breast Cancer, Era of Hope Scholar Award
Last updated: August 19, 2026
Posted May 4, 2026
Funding
Funding amount not specified
Closes
July 8, 2026
NAICS
541715
Similar grants still open
- Applied Drug Policy Research ExperiencesOffice of National Drug Control Policy · closes September 6, 2026
- Building Lasting U.S.-Chad Partnerships to Promote American ExcellenceU.S. Mission to Chad · closes September 6, 2026
- Alcohol Health Services Research (R01 Clinical Trial Optional)National Institutes of Health · closes September 7, 2026
- Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)National Institutes of Health · closes September 7, 2026
- Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)National Institutes of Health · closes September 7, 2026
- Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)National Institutes of Health · closes September 7, 2026
- Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)National Institutes of Health · closes September 7, 2026
- National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)National Institutes of Health · closes September 7, 2026
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Era of Hope Scholar Award supports individuals who are early in their careers with significant potential to effect meaningful change in breast cancer. As the Intent of the FY26 BCRP Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the award’s central features include the Principal Investigator’s (PI’s) demonstrated ability to go beyond conventional thinking in their field and the innovative and meaningful contributions that they can make toward ending breast cancer. The Era of Hope Scholar Award requires exceptionally talented scientists that are among “the best and the brightest” in their field(s), with demonstrated experience forming effective partnerships and collaborations and strong potential for future leadership in breast cancer research. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Distinctive Features: · The PI must commit a minimum of 25% level of time and effort during the period of performance to conduct breast cancer research under this award. · The research team must include two or more breast cancer consumer advocates.
Eligibility
- Funded by Army
Award details
Applications close on July 8, 2026.
Categories
Not categorized
This grant is no longer accepting applications. Get matched to open grants like it, or browse the ones above.
See similar open grants ↑Applications closed — listing kept for reference.·Source: Grants.gov·Last seen Jul 7, 2026
